What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Gene
His primary areas of study are Immunology, Autoimmune disease, Autoimmunity, Internal medicine and Rheumatoid arthritis.
His work deals with themes such as Single-nucleotide polymorphism, Allele and Genetic predisposition, which intersect with Immunology.
His Autoimmune disease study incorporates themes from Systemic disease, Autoantibody, Case-control study and Single patient.
Juan Manuel Anaya interconnects Family aggregation and Antiphospholipid syndrome in the investigation of issues within Autoimmunity.
In his work, Autoimmune hepatitis, Hepatitis and Infliximab is strongly intertwined with Gastroenterology, which is a subfield of Internal medicine.
His Rheumatoid arthritis research is multidisciplinary, relying on both Liver biopsy, Tuberculosis and Arthritis.
His most cited work include:
- Human polymorphism at microRNAs and microRNA target sites. (1284 citations)
- Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases (367 citations)
- Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome. (288 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Immunology, Internal medicine, Rheumatoid arthritis, Autoimmune disease and Autoimmunity.
His study in Immunology is interdisciplinary in nature, drawing from both Single-nucleotide polymorphism and Disease.
His Single-nucleotide polymorphism research integrates issues from Allele and Haplotype.
His Internal medicine research incorporates themes from Gastroenterology and Endocrinology.
His Rheumatoid arthritis study combines topics in areas such as Methotrexate, Arthritis, Cross-sectional study, HLA-DRB1 and Physical therapy.
His Autoimmune disease study focuses on Connective tissue disease in particular.
He most often published in these fields:
- Immunology (53.69%)
- Internal medicine (23.71%)
- Rheumatoid arthritis (21.03%)
What were the highlights of his more recent work (between 2015-2021)?
- Immunology (53.69%)
- Autoimmunity (15.21%)
- Guillain-Barre syndrome (4.03%)
In recent papers he was focusing on the following fields of study:
Juan Manuel Anaya mostly deals with Immunology, Autoimmunity, Guillain-Barre syndrome, Autoantibody and Disease.
His study involves Autoimmune disease, Molecular mimicry, Immune system, Virus and Immune tolerance, a branch of Immunology.
His studies deal with areas such as Autoimmune hepatitis, Antiphospholipid syndrome and Primary immunodeficiency as well as Autoimmunity.
His research integrates issues of Cytokine, Genetic predisposition and Anti-SSA/Ro autoantibodies in his study of Autoantibody.
His study on Disease is covered under Internal medicine.
The Internal medicine study combines topics in areas such as Gastroenterology and Endocrinology.
Between 2015 and 2021, his most popular works were:
- Convalescent plasma in Covid-19: Possible mechanisms of action. (186 citations)
- Molecular mimicry and autoimmunity (96 citations)
- Original antigenic sin: A comprehensive review. (77 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
His scientific interests lie mostly in Immunology, Autoimmunity, Disease, Guillain-Barre syndrome and Molecular mimicry.
His Immunology study typically links adjacent topics like Allele.
His work carried out in the field of Autoimmunity brings together such families of science as Autoimmune disease, Immune dysregulation, Antiphospholipid syndrome, Autoimmune hepatitis and Primary immunodeficiency.
In his study, Rheumatoid arthritis is strongly linked to Comorbidity, which falls under the umbrella field of Autoimmune hepatitis.
His biological study spans a wide range of topics, including Precision medicine, Systems biology, Health care and Preventive healthcare.
Juan Manuel Anaya combines subjects such as Cellular immunity, Systematic review, Muscle weakness, Transverse myelitis and Zika virus with his study of Guillain-Barre syndrome.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
